Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 5:32 PM View:  | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 34% 6.5K to 8.74K | |
| 23-Jun-23 7:04 PM View: | Blueprint Medicines Corp (BPMC) | 21-Jun-23 | Grant | 2,600 | -- | -- | 67% 3.9K to 6.5K | |
| 27-Jun-22 6:45 PM View: | Blueprint Medicines Corp (BPMC) | 23-Jun-22 | Grant | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 22-Nov-21 9:02 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 98,450 | -- | -- | (100%) 98.45K to 0 | |
| 02-Jul-21 9:15 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jul-21 | Option Exercise | 42,186 | $35.04 | $1,478,200.00 | 43% 98.45K to 140.64K | |
| 02-Jul-21 9:15 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jul-21 | Market Option Sale (Planned) | 42,186 | $126.97 | $5,356,350.00 | (30%) 140.64K to 98.45K | (42%) |
| 02-Jul-21 9:15 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-21 | Option Exercise | 57,814 | $35.04 | $2,025,800.00 | 59% 98.45K to 156.26K | |
| 02-Jul-21 9:15 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-21 | Market Option Sale (Planned) | 57,814 | $126.73 | $7,326,590.00 | (37%) 156.26K to 98.45K | (42%) |
| 02-Feb-21 7:10 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 16,662 | -- | -- | 20% 81.79K to 98.45K | |
| 06-Jan-21 6:58 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jan-21 | Market Sale (Planned) | 4,258 | $121.13 | $515,774.00 | (5%) 86.05K to 81.79K | (48%) |
| 06-Jan-21 6:58 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Payment of Exercise | 3,278 | $124.31 | $407,488.00 | (4%) 89.32K to 86.05K | (45%) |
| 06-Jul-20 6:57 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-20 | Option Exercise | 50,000 | $35.04 | $1,752,000.00 | 56% 89.32K to 139.32K | |
| 06-Jul-20 6:57 PM View: | Acceleron Pharma Inc (XLRN) | 01-Jul-20 | Market Option Sale (Planned) | 50,000 | $96.41 | $4,820,450.00 | (36%) 139.32K to 89.32K | (86%) |
| 24-Jan-20 5:18 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 22,173 | -- | -- | 33% 67.15K to 89.32K | |
| 03-Jan-20 9:37 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-20 | Market Sale (Planned) | 3,732 | $51.24 | $191,230.00 | (5%) 70.88K to 67.15K | (251%) |
| 10-Sep-19 8:21 PM View: | Acceleron Pharma Inc (XLRN) | 10-Sep-19 | Market Sale (Planned) | 5,625 | $45.23 | $254,412.00 | (7%) 76.51K to 70.88K | (297%) |
| 11-Apr-19 4:58 PM View: | Acceleron Pharma Inc (XLRN) | 09-Apr-19 | Market Sale (Planned) | 7,460 | $44.60 | $332,748.00 | (9%) 83.97K to 76.51K | (303%) |
| 29-Jan-19 5:37 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 17,700 | -- | -- | 27% 66.27K to 83.97K | |
| 04-Jan-19 6:34 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-19 | Market Sale (Planned) | 1,957 | $43.41 | $84,961.50 | (3%) 68.22K to 66.27K | (314%) |
| 06-Dec-18 4:22 PM View: | Acceleron Pharma Inc (XLRN) | 04-Dec-18 | Market Sale (Planned) | 12,675 | $52.99 | $671,610.00 | (16%) 80.9K to 68.22K | (239%) |
| 05-Mar-18 5:13 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 18,100 | -- | -- | 29% 62.8K to 80.9K | |
| 05-Dec-16 4:16 PM View: | Acceleron Pharma Inc (XLRN) | 01-Dec-16 | Grant | 62,800 | -- | -- | 100% 0 to 62.8K |